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 1 
Abstract 
The development of the cerebral cortex is a complex process that requires the generation, 
migration, and differentiation of neurons. Interfering with any of these steps can impair the 
establishment of connectivity and, hence, function of the adult brain. Neurotransmitter 
receptors have emerged as critical players to regulate these biological steps during brain 
maturation. Among them, α2 subunit-containing glycine receptors (GlyRs) regulate cortical 
neurogenesis and the present work demonstrates the long-term consequences of their genetic 
disruption on neuronal connectivity in the postnatal cerebral cortex. Our data indicate that 
somatosensory cortical neurons of Glra2 knockout mice (Glra2KO) have more dendritic 
branches with an overall increase in total spine number. These morphological defects 
correlate with a disruption of the excitation/inhibition balance, thereby increasing network 
excitability and enhancing susceptibility to epileptic seizures after pentylenetetrazol tail 
infusion. Taken together, our findings show that the loss of embryonic GlyRα2 ultimately 
impairs the formation of cortical circuits in the mature brain.  
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Introduction 
The cerebral cortex is an evolutionary advanced structure of the brain that processes sensory 
information, controls motor output and mediates higher-order cognitive functions. Its well-
orchestrated development extends from embryogenesis to postnatal stages (Lui et al., 2011) 
and involves a tight regulation of birth, migration and differentiation of several subtypes of 
neurons into six layers (Rakic et al., 1994, Rakic, 2009, Lui et al., 2011). Disruption of this 
cellular regulatory logic is often associated with the etiology of epilepsy, autism spectrum 
disorder (ASD), schizophrenia, and intellectual disabilities (Lee et al., 1997, Lewis and Levitt, 
2002, Valiente and Marin, 2010, Geschwind and Rakic, 2013, Pilorge et al., 2015). A 
prominent trait of the cerebral cortex is its complex cellular architecture, which relies on its 
high degree of neuronal diversity (Greig et al., 2013). Cortical neurons are generated during 
development and can be canonically subdivided into projection neurons (PNs), which forward 
excitatory signals and the interneurons (INs), which relay inhibition in the cortical circuitry 
(Molyneaux et al., 2007, Huang, 2014). Growth of cortical neuron dendritic arborization 
accelerates during the early postnatal developmental window leading to a thickening of the 
developing cortex, which further coincides with an increase rate of synaptogenesis 
(Huttenlocher, 1979, Huttenlocher and Dabholkar, 1997). Indeed, cortical neurons initially 
established high numbers of synapses that are progressively eliminated during development to 
form stable mature circuitry in the adult cerebral cortex (Huttenlocher, 1979, Huttenlocher 
and Dabholkar, 1997, Harris and Mrsic-Flogel, 2013).  
Several lines of evidence indicate that the microenvironment of the developing cortex plays 
instructive roles during embryogenesis. Along this line, neurotransmitters have a central role 
during corticogenesis (Ruediger and Bolz, 2007) and disrupting their signaling accounts for 
impaired brain functions resulting from either reduction, misplacement or poor maturation of 
specific neuronal populations in the cortex (Represa and Ben-Ari, 2005, Avila et al., 2013a, 
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Avila et al., 2013b, Avila et al., 2014). GlyRs are ligand-gated chloride channels expressed in 
the cerebral cortex either as homopentamers of α subunits, or as complexes of two α and three 
β subunits (Betz and Laube, 2006). Four α subunit isoforms (α1-α4) and one β subunit variant 
have been identified and significant progress has been made in the understanding of the 
biological roles of GlyRs via studies of mutant mice (Malosio et al., 1991, Flint et al., 1998, 
Betz and Laube, 2006, Avila et al., 2013b, Avila et al., 2014). Most cortical GlyRs are α2 
homomers during embryogenesis and at birth (Young-Pearse et al., 2006). Moreover, recent 
work reported the integration of α3 subunits in GlyRs expressed by neurons from layers II/III 
and also V and VI of the somatosensory cortex (Sorensen et al., 2013). However, 
physiological studies of GlyRs in PNs of layer II/III and V/VI of the prefrontal cortex 
indicated a lack of glycinergic synapses, rather suggesting that GlyRs were tonically activated 
in PNs (Liu et al., 2014, Salling and Harrison, 2014). Interestingly, α2 subunit GlyRs are 
pivotal for brain development. Both cortical PNs and INs express functional GlyRs during 
embryogenesis (Flint et al., 1998, Avila et al., 2013b, Avila et al., 2014) and genetic 
inactivation of Glra2 disrupted dorsal cortical progenitor homeostasis. This defect resulted in 
a global reduction of PNs number that settle in the upper or deep layers of the cerebral cortex. 
Overall, the depletion of cortical neurons observed in Glra2KO embryos contributes to 
moderate microcephaly in newborn mice (Avila et al., 2014). Furthermore, disruption of GlyR 
activity impairs tangential migration of INs from the medial ganglionic eminence (MGE) to 
the cerebral cortex, thus leading to an overall reduction of INs at birth (Avila et al., 2013b, 
Avila et al., 2014). Loss of function mutations of Glra2 are associated with ASD in humans 
and loss of Glra2 in mice causes early developmental defects of cortical neurons (Piton et al., 
2011, Avila et al., 2013b, Avila et al., 2014, Iossifov et al., 2014, Pilorge et al., 2015). 
However, it remains unclear if embryonic defects resulting from loss of glycine signaling 
underlie ASD through poor cortical network maturation.  
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The present work explores the consequences of the embryonic loss of GlyR α2 homomers in 
the establishment of mature and functional cortical networks. We show a significant reduction 
of the number of INs and PNs residing in upper layers and layer V of postnatal Glra2KO 
mice. Furthermore, we demonstrate that cortical neurons of layer V have impaired dendrite 
and spine morphologies that are associated with synaptogenesis defects during cortical 
maturation. These morphological alterations are associated with functional defects that lead to 
a marked disruption of excitatory and inhibitory input-output of the cerebral cortex 
culminating in increased network excitability following treatment with 4 aminopyridine (4-
AP) in vitro. In addition, in vivo experiments confirmed that adult Glra2KO mice show 
increased susceptibility to epileptic seizures after pentylenetetrazol (PTZ) injections. 
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Results 
Genetic inactivation of Glra2 leads to reduced number of cortical neurons after birth  
Glycine receptors composed of α2 subunits are widely distributed in the forebrain (Malosio et 
al., 1991). Previous work from our laboratory demonstrated that Glra2KO embryos have 
reduced number of PNs in several cortical layers and suffer from microcephaly (Avila et al., 
2014). In addition, we showed that Glra2 expression is required for proper migration of 
cortical INs from MGE to cerebral cortex (Avila et al., 2013b, Avila et al., 2014). At P7, 
Glra2KO animals showed a moderate microcephaly characterized by reduced brain weight 
and cerebral cortical wall thickness (Figures 1a-1b). This phenotype gradually toned down 
with age; it was less pronounced at P14 (Figures S1a-S1b) and not seen in adulthood (Pilorge 
et al., 2015). We next assessed the laminar composition of the cortex at P7 and P14 and 
observed less upper layer neurons expressing Cux1 (Figures 1c-S1c) as well as less Ctip2+ 
(strong labeling) sub-cerebral PNs (mostly layer V) in Glra2KO mice, as compared to WT 
littermates (McKenna et al., 2011) (Figure 1d-S1d). Surprisingly, the number of cortico-
thalamic PNs of layer VI, which co-express Tbr1 and Ctip2 (weak labeling) remained 
unchanged between genotypes (Figure 1d-S1d) (McKenna et al., 2011). We next assessed the 
population of cortical INs using a GFP reporter mouse line (Dlx5,6:Cre-IRES-EGFP, later 
mentioned as Dlx 5-6) that we crossed with Glra2KO mice. Dlx 5-6 INs represent 75-80% of 
the total population of cortical interneurons born in the MGE and caudal ganglionic 
eminences (CGE) (Marin, 2012). We observed an overall reduction of the number of GFP-
expressing INs without layering alteration in the cerebral cortex of P7 and P14 Glra2KO 
mice, as compared to controls (Figures 2a-S1e). These results were comparable to those 
previously observed during embryogenesis (Avila et al., 2013b). The population of Dlx 5-6 
INs deriving from the MGE mainly specializes into parvalbumin (PV) and somatostatin (SST) 
expressing interneurons (Marin, 2012). PV interneurons mostly target the soma of PNs and 
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are thought to control the synchrony of network gamma oscillations in the brain (Hu et al., 
2014). On the other hand, SST interneurons innervate local PV interneurons, placing them in 
an ideal position to drive inhibition and directly mediate plasticity mechanisms via the 
inhibition of incoming information to the distal dendrites of pyramidal neurons (Silberberg 
and Markram, 2007, Hioki et al., 2013). While both number and layering distribution of SST-
positive INs were similar in both genotypes at P7 and P14 (Figures 2b-S1f), immunolabelings 
of brain sections from P14 Glra2KO mice showed a 20% reduction of PV-expressing 
interneuron number without disruption of their layering (Figure 2c). Dlx 5-6 cells born in 
CGE predominantly specify into calretinin-positive (CR) interneurons, which inhibit INs and 
PNs by targeting soma and apical dendrites. During early postnatal development, most CR-
positive INs settle in cortical layers II-III and few populate layer V. During adulthood, these 
neurons are widely distributed throughout the cortex (Barinka and Druga, 2010). Our results 
showed a significant reduction of the number of CR-expressing INs at P7 upon depletion of 
Glra2 (Figure 2d).  
Overall, the somatosensory cortex of Glra2KO mice is characterized by a quantitative 
reduction of both PNs and INs likely resulting from the proliferation and migration defects 
occurring during embryogenesis (Avila et al., 2013b, Avila et al., 2014). These data suggest a 
possible impairment of cortical network connectivity. For this purpose, we assessed the 
formation and activity of the Glra2KO mouse cortical neuronal network at late postnatal ages. 
 
Morphological defects of layer V neurons in the cerebral cortex of Glra2KO animals 
We performed reconstructions of biocytin-filled layer V PNs from P7 animals to assess their 
morphological development and spine density. Cellular identity was confirmed by 
morphological and electrophysiological characteristics (Christophe et al., 2005, Hattox and 
Nelson, 2007) (Figures 3a, 5a-b). We observed an increase of total dendritic length, which 
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was associated with more branching points (Figure 3a). Sholl analyses made separately on 
apical and basal dendrites revealed more distal branching of basal dendrites upon loss of 
Glra2 while apical dendrite branching complexity was comparable between genotypes at P7 
(Figure 3b). When assessed at the dendrite level, spine density of layer V neurons from 
Glra2KO mice was reduced both in basal (Figure 3c) and apical dendrites (data not shown). 
However, according to total dendritic length increase, the total number of spines (total 
dendritic length*spine density) per neuron was increased in Glra2KO mice, as compared to 
WT littermate (Figure 3c). In order to discriminate excitatory inputs at the level of dendritic 
shafts and spines, we monitored the expression of the post-synaptic protein PSD95 in biocytin 
filled layer V PNs dendrites. PSD95 is expressed in the shaft, dendritic spines and soma 
binding directly NMDA receptors via an integral PDZ domain (Kornau et al., 1995) and 
indirectly to AMPA receptors through stargazin (Bats et al., 2007). It has been reported that in 
brain slices or neuronal cortical cultures from young animals the excitatory input to the 
dendritic tree is unequally shared between spines (36%) and shaft (64%), whilst in adult 
synaptic connections occurred mainly at the level of spines (Boyer et al., 1998). We observed 
an overall increase of PSD95 boutons in the dendrites of Glra2KO layer V PNs (Figure 3d). 
Indeed, the percentage of PSD95 boutons was decreased in spines (38.00±1.67% in WT vs 
23.6±1.62% in Glra2KO) and largely increased in shafts upon deletion of in Glra2 
(62.00±1.67% in WT vs 76.4±1.62% in Glra2KO) (data not shown). Such defects may indeed 
arise from the poor maturation of dendritic spines in Glra2KO layer V PNs as revealed by 
Golgi staining showing a significant increase of immature spines (filamentous) at the expense 
of mature spines (mushroom shaped) (Figure S2). Interestingly, the enrichment in filamentous 
spines alongside the increased branching is a common feature of several neurodevelopmental 
X-linked pathologies and epilepsy models (Irwin et al., 2000, Ma et al., 2013). 
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We subsequently analyzed the morphology of GFP+ cortical INs to assess local circuitry 
defects in the layer V of Glra2KO mouse cortex. We thus performed morphological 
reconstructions of layer V fast-spiking INs (Figures 4a, 5d-e). The total dendritic length was 
increased and was associated with more complex branching upon loss of Glra2 (Figure 4a). 
Sholl analyses confirmed the increased dendrite ramification of Glra2KO INs (Figure 4b). We 
further analyzed dendritic spines, which are present in several subtypes of INs in 
hippocampus and cortex (Kawaguchi et al., 2006). Our data showed reduced spine density in 
secondary dendrites as well as an increase of total number of dendritic spines per Glra2KO 
IN, as compared to WT IN (total dendritic length*spine density) (Figure 4c). Not only 
dendritic spines but also shafts correspond to sites of postsynaptic excitatory inputs on INs 
(Scheuss and Bonhoeffer, 2014), thus we analyzed the expression of PSD95 at the dendritic 
level of INs. We observed an increased density of PSD95 positive boutons in Glra2KO layer 
V INs (Figure 4d). Taken together, these experiments revealed branching and spinogenesis 
defects upon Glra2 deletion for both PNs and INs that populate the layer V of the 
somatosensory cortex, further supporting possible alterations in their connections after birth. 
 
Functional defects of layer V neurons in the cerebral cortex of postnatal Glra2KO mice 
To test whether the dendritic alterations of layer V neurons impair their connections, we 
performed whole-cell patch-clamp recordings to measure spontaneous excitatory and 
inhibitory postsynaptic currents (sEPSCs and sIPSCs, respectively) at P7. Layer V PNs are 
either callosal (projecting within the cerebral cortex) or subcortical (targeting the thalamus, 
the midbrain, the hindbrain and the spinal cord) neurons. Here, we focused on P7 layer V 
subcortical PNs acting as main output from cortex to lower brain regions. At P7, these 
neurons are characterized by the extension of the apical dendrite into layer I with elaborated 
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apical tufts as well as by electrophysiological parameters (specific input resistance, membrane 
capacitance and resting potential) (Figure 3a-5a,b) (Koester and O'Leary, 1992, Christophe et 
al., 2005, Hattox and Nelson, 2007). Patch-clamp recordings revealed increased frequency of 
spontaneous postsynaptic currents (sPSCs) in layer V PNs that lack Glra2 expression, as 
compared to WT PNs (Figure 5c). Moreover, after blocking sIPSCs by infusing GABAAR 
antagonists (10 μM gabazine or 10 µM bicuculline methiodide), we observed an increased 
frequency of sEPSCs in Glra2KO neurons (Figure 6a). Additionally, we calculated the charge 
transfer of the averaged sEPSCs as a measure of the membrane depolarizing capacity of the 
current. The averaged sEPSCs charge per event (670.7±184.1 fC in Glra2KO vs 289.2±55.9 
fC in WT; p value<0.05) and charge transfer were significantly increased in Glra2KO, and 
were associated with a reduction in rise time in the Glra2KO layer V neurons at P7 compared 
to WT neurons (Figures 6a and S3a). In strike contrast, the frequency of sIPSCs - measured 
after addition of CNQX (5 µM) and AP5 (5 µM) - was significantly reduced in Glra2KO 
layer V PNs (Figure 6c). We also observed a correlated reduction of charge transfer of 
averaged sIPSCs due to the reduction of rise time and amplitude (Figures 6c and S3b). 
Infusion of 1µM of tetrodotoxin (TTX) blocked action potential-dependent events and 
allowed us to measure mini post-synaptic currents (mPSCs). Recordings made at P7 showed 
that Glra2KO layer V PNs had increased frequency of mEPSCs (Glra2KO 0.209±0.048 Hz 
versus WT 0.091±0.024 Hz n=6 and 6 p<0.05) and conversely, reduced frequency of mIPSCs, 
as compared to their controls (Glra2KO 0.073±0.020 Hz versus WT 0.262±0.073 Hz n=6 and 
6 p<0.01) (data not shown). 
To assess the local microcircuitry of layer V in Glra2KO mice, we evaluated the synaptic 
activity of GFP+ INs. We thus selected fast-spiking GFP+ INs (Daw et al., 2007, Hu et al., 
2014, Yang et al., 2014) (Figure 5d-e) to analyze sEPSCs and sIPSCs at P7. Glra2KO INs 
showed more sPSCs, as compared to WT INs (Figure 5f). We recorded an increased 
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frequency of sEPSCs in presence of GABAAR antagonists in P7 Glra2KO INs as compared 
to their controls (Figure 7a). Measurements of the averaged sEPSCs charge per event 
(805.1±180.9 fC in Glra2KO vs 419.3±74.8 fC in WT; p value<0.05) and charge transfer 
showed a clear shift toward excitation for INs in Glra2KO mice, suggesting an overall 
increased membrane excitation (Figure 7a). These results were associated with a reduction of 
rise time and increased decay time (Figure S3c). On the other hand, the frequency of sIPSCs 
recorded after pharmacological addition of glutamatergic blockers (5 µM of CNQX and AP5) 
was significantly decreased upon genetic deletion of Glra2 (Figure 7c). This reduction was 
associated with a decreased charge transfer in Glra2KO INs, as compared to controls, 
associated with an increased rise time and decay time (Figure 7c and S3d). mEPSCs were 
increased in Glra2KO INs (Glra2KO 0.278±0.065 Hz versus WT 0.1±0.034 Hz n=6 and 6 
p<0.05), whilst mIPSCs were reduced in Glra2KO INs, as compared to control INs (Glra2KO 
0.041±0.011 Hz versus WT 0.112±0.025 Hz n=6 and 6 p<0.05) (data not shown). The 
synaptic phenotype of Glra2KO layer V neurons did not result from compensation by other 
GlyR subunits (Figures S4-S5). Indeed, we found that the molecular composition of GlyRs 
was dynamically remodeled during the development in the somatosensory cortex (Figures 
S5a-S5f). The expression of α2 subunits predominated during embryonic development, while 
other GlyR subunits showed a progressive enrichment during mouse brain development. 
Moreover, layer V PNs and INs expressed functional extrasynaptic GlyRs at P7 in both WT 
and Glra2KO mice (Figures S4a-S4c). These receptors were tonically activated, as 
application of 1µM strychnine did not alter the frequency of sPSCs recorded in cortical 
neurons from both genotypes (Figure S4b-S4d). These results also supported previous 
observations made in prefrontal cerebral cortex PNs (Liu et al., 2014, Salling and Harrison, 
2014).  
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The functional synaptic defects measured by patch-clamp recordings suggested impairment of 
both excitatory and inhibitory synapse densities. We thus analyzed the expression of specific 
excitatory (PSD95) and inhibitory (glutamic acid decarboxylase-65, or GAD65) synaptic 
markers at the perisomatic level of layer V GFP+ INs and Ctip2+ subcortical-targeting PNs. 
The analysis of P7 Glra2KO cortices revealed increased density of PSD95-expressing 
(Figures 6b and 7b) and reduced density of GAD65-expressing (Figures 6d and 7d) 
perisomatic boutons in both PNs and INs. Altogether, these data support a possible disruption 
of the balance between excitatory and inhibitory connections in neurons from layer V of the 
Glra2KO cortex of postnatal mice (Figures 8a-8b). 
  
Genetic inactivation of Glra2 increases susceptibility to chemoconvulsant-induced epileptic 
seizures 
The morphological and functional alterations observed in the layer V circuitry of Glra2KO 
mice suggest that they may be prone to seizures upon challenging conditions. To check this 
hypothesis, we performed in vitro recordings of adult layer V PNs in the presence of 4-AP, 
which enhances transmitter release at both inhibitory and excitatory terminals (Buckle and 
Haas, 1982), thus inducing network driven interictal-like discharge via the block of A- and D-
type K+ mediated currents (Traub et al., 1995). Layer V PNs recorded in adult mice never 
showed ictal discharge during bath application of 50 µM 4-AP (n=4 for both genotypes) 
(Figure 8c). Interestingly, at 100 µM 4-AP most layer V PNs recorded in Glra2KO mouse 
cortices exhibited ictal discharges as compared to WT (n=6 per genotype) (Figure 8c). Bath-
perfusion of 500 µM 4-AP (n=3 per genotype) induced ictal activity and afterdischarge in 
both genotypes with an averaged time-to- ictal event (TTI, the interval between the beginning 
of stimulation with proconvulsant and the appearance of the ictal event) of 67±8.5 seconds for 
Glra2KO and 88.3±4.1 in WT adults (data not shown). Next, we compared the behavior of 
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adult Glra2KO and WT mice infused with PTZ, a chemoconvulsant used for seizure test 
(Loyens et al., 2012) (Figure 8d). Two types of motor seizures are elicited by PTZ: minimal 
seizures, restricted to forelimbs and predominantly clonic; and major seizures which consists 
of a generalized tonic-clonic response that contracts the muscles of the whole body leading to 
cramped tonic state (Depaulis et al., 1989). Specifically, PTZ was infused in the tail vein of 
Glra2KO and WT littermates in order to measure seizure thresholds. Depletion of Glra2 
significantly decreased PTZ thresholds for all the following mild and severe behaviors: ear 
twitch, myoclonic twitch, forelimb clonus, falling, tonic hindlimb extension (THE) and death 
(Figure 8d). The increased seizure susceptibility observed in Glra2KO mice treated with PTZ, 
suggests a critical role of α2 GlyRs for proper establishment of the cortical circuitry during 
brain maturation. 
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Discussion 
Neurotransmitters belong to the microenvironment of neuronal progenitors and some act 
extrasynaptically to promote their maturation into functional neurons (Nguyen et al., 2001, 
Heng et al., 2007). We recently demonstrated that on the one hand, α2 GlyRs expressed at 
embryonic stages control neurogenesis and neuronal migration of cortical progenitors, thereby 
setting a stable basis for network construction (Avila et al., 2013b, Avila et al., 2014). Here 
we show that Glra2KO mice have moderate microcephaly at P7 and P14 that likely arises 
from a reduced production of PV- and CR-expressing INs, as well as PNs dedicated to most 
cortical layers. After birth, the α2 GlyRs remain expressed in the cerebral cortex (Becker et 
al., 1993, Young-Pearse et al., 2006), suggesting they might modulate cortical network 
maturation and homeostasis. In this work, we present evidence indicating that functional 
GlyR α2 homomers control the morphological differentiation and functional integration of 
layer V neurons and interneurons into the cortical network. Absence of Glra2 led to the 
formation of cortical network prone to over-excitability, as further supported by the higher 
susceptibility of Glra2KO mice to epileptic seizures induced by PTZ tail infusion, as 
compared to WT littermates.  
Our data suggest a critical role for α2 GlyRs in the fine control of branching and 
synaptogenesis of cortical PNs and fast spiking INs of layer V at P7. Both neuronal 
populations displayed an increase of dendritic complexity and total number of spines in the 
cortex of P7 Glra2KO mice, as compared to WT littermates (Figure 8a and 8b). It is 
noteworthy that the dendritic field and the spines undergo significant changes in shape and 
number in response to neuronal activity (Yuste and Bonhoeffer, 2004). Thus, the branching 
phenotype that we observed in layer V neurons of Glra2KO may partly be cell autonomous 
and result from loss of glycinergic signaling in layer V neurons and partly non-cell 
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autonomous as a result of disturbed synaptic input from upstream neurons onto layer V 
neurons.  
Accumulation of morphological defects in cortical neurons upon Glra2 inactivation lead to 
alterations in synaptic communication. The overall reduction of inhibitory synaptic efficacy 
(INs to INs and INs to PNs) is paralleled by an increased excitatory synaptic activity of the 
PNs to PNs and PNs to INs. Glutamatergic neurons form multiple synapses onto INs and PNs 
at somatic and dendritic level. In the INs, glutamatergic synapses typically form clusters on a 
small fraction of dendrites, whilst these synapses are widespread and highly innervate PNs 
(Buhl et al., 1997). The present work reports an increased number of excitatory synapses at 
the dendrites and soma of both PNs and INs from Glra2KO mice, as compared to WT 
littermates (Figures 8a and 8b). Such defects may lead to a global modification of the output 
balance toward excitation in both PNs and INs. Although an increased excitation of INs might 
result in increased inhibitory input on PNs, the decreased number of INs in layer V probably 
counteract the effect of the increased inhibition at the single IN level. According to the 
decreased rheobase and increased excitatory charge transfer (Figure 5b and 6a), Glra2KO 
layer V PNs are likely more excitable as compared to their WT controls. Together, our results 
support an alteration of synaptogenesis of cortical neurons in postnatal Glra2KO mice, 
leading to an increase in the global output of layer V neurons of the cerebral cortex.  
The physiological consequences of a modified excitation/inhibition balance in cortical 
network may underlie epilepsy. We thus investigated the epileptiform activity in the cortical 
circuitry of Glra2 KO mice at the cellular level using bath application of 4-AP (Avoli and 
Olivier, 1989, Tasker et al., 1992), or in vivo after tail vein infusion of the chemoconvulsant 
PTZ (Loyens et al., 2012). Here, we report higher susceptibility to lower concentration of 4-
AP-induced interictal-like discharges in PNs of the layer V recorded in brain slices from adult 
Glra2KO mice suggesting a higher susceptibility to epileptic brain activity. Moreover, the in 
 15 
vivo experiments showed that lower PTZ doses are required to trigger the typical seizure-
related behaviors in Glra2KO mice, as compared to WT littermates, supporting an increased 
susceptibility to epileptic seizures upon inactivation of Glra2.  
Three recent studies showed genetic anomalies in the Glra2 gene associated with ASD in 
humans (Piton et al., 2011, Iossifov et al., 2014, Pilorge et al., 2015). Loss of function of α2 
GlyRs impaired synaptic plasticity and social and cognitive impairments (Pilorge et al., 2015). 
The disrupted excitation-inhibition balance of layer V circuits reported in the present work 
may account for the etiology of ASD as well as comorbid epilepsy. In general, epilepsy is a 
common condition occurring in up to 30% of the ASD patients, especially those with 
intellectual disabilities confirming the link with cortical anomalies (Lai et al., 2014). 
Furthermore, the idea of a connection between genetic modification of GlyRs and epilepsy 
has already been proposed by several in vitro and clinical studies. In vitro studies have 
demonstrated that glycine depresses cell-bursting activity in the hippocampus under 
hyperexcitable conditions via GlyR activation (Chattipakorn and McMahon, 2003). This was 
consistent with the idea that activation of GlyRs is required to suppress the generation of 
epileptiform discharges in the hippocampus of young rats (Chattipakorn and McMahon, 2003, 
Song et al., 2006, Chen et al., 2014). Finally, some mutations of GlyR subunit-coding genes 
have been associated with epilepsy in human (Eichler et al., 2009, Epi and Epilepsy 
Phenome/Genome, 2013, Pilorge et al., 2015).  
In summary, our results demonstrate a physiological role for α2 GlyRs during cortical 
network formation and homeostasis. Moreover, we suggest that disruption of Glra2 
expression in humans might lead to cortical neuronal migration as well as maturation defects 
that increased susceptibility to epileptic seizures. 
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Materials and methods  
Animals. All animal experimental procedures were performed following guidelines of local 
ethical committees at Hasselt and Liège Universities as well as at the Vrije Universiteit 
Brussel. Glra2KO mice (Avila et al., 2013b) were backcrossed onto the MF1 background, and 
some were crossed with Dlx5,6:Cre-IRES-EGFP (Stenman et al., 2003) for selected 
experiments and housed at the BIOMED Institute animal facility. C57BL/6J Glra2KO mice 
were used for behavioral experiments after confirmation of similar defects in the cerebral 
cortex as the MF1 mouse line for Glra2KO. 
Immunohistochemistry. Postnatal day 7 and 14 mice were transcardially perfused with PBS 
followed by 4% PFA in PBS and post-fixed by immersion in the same fixative overnight at 
4°C. Brains were cut in 20 µm slices for all experiments. Primary antibodies in this study 
include the following: goat anti-Cux1 (1:25; Sc-6327, Santa Cruz Biotechnologies, USA), rat 
anti-Ctip2 (1:200; ab18465, Abcam, UK), rabbit anti-Tbr1 (1:200; ab31940, Abcam, UK), 
mouse anti-PV (1:500, MAB 1572, Millipore, USA), mouse anti-calretinin (1:1000, mab1568, 
Millipore) rat anti-somatostatin (1:50, mab354, Millipore, USA), mouse anti-GAD65 (1:20; 
Developmental studies hybridoma bank, USA), rabbit anti-PSD95 (1:100; ab18258, Abcam, 
UK), mouse anti-NeuN clone A60 (1:100, Millipore, USA), rabbit anti-NeuN (1:100, 
Millipore) and rabbit anti-GFP (1:200; ab6556, Abcam, UK). Specific secondary antibodies 
Alexa 488, 555 and 647 (A555, A647 and A488, Life Technologies, Belgium) were used. 
Electrophysiology. PNs and GFP+ INs of somatosensory cortex in the layer V were identified 
by morphological, electrophysiological criteria and expression of GFP. Localization of layer 
V was visually obtained by recognition of barrel somatosensory cortex. Whole-cell patch-
clamp recordings were performed using an Heka EPC9 (Heka elektronik, Germany) patch-
clamp amplifier. All experiments were carried out at room temperature, in voltage-clamp 
mode at a holding voltage equal to -60 mV. All ligands and blockers were either bath applied 
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or focally applied. The internal solution was composed by KCl 130, NaCl 5, CaCl2 1, MgCl2 
1, Hepes 10, EGTA 10, NaATP 2, NaGTP 0.5 (mM) and 5% biocytin (pH adjusted to 7.3 
with KOH) whilst the external artificial cerebrospinal fluid (ACSF) solution was composed 
by NaCl 125, KCl 2.5, MgCl2 1, CaCl2 2, NaHCO3 25, NaH2PO4 1.25, Glucose 25 for P7 
mice and 10 for adult mice (mM). Spontaneous post-synaptic currents (sPSCs) were obtained 
by 2 minutes recordings of spontaneous events. To detect sIPSCs 5 µM 6-cyano-7-
nitroquinoxaline-2,3-dione, CNQX (C239, Sigma, Belgium), and 5 µM (2R)-amino-5-
phosphonovaleric acid, AP5 (A8054, Sigma, Belgium), were added to the bath before 
recording. To detect sEPSCs 10 µM of bicuculline methiodide (14343, Sigma, Belgium) was 
added to the ACSF. This was confirmed using also 10 µM gabazine (S106, Sigma, Belgium), 
isomer of bicuculline. After 5 minutes of bath perfusion in order to allow the drugs to be 
effective, 2 minutes recordings were measured. Experimental approach to detect mPSCs was 
equivalent as the sPSCs with addition of 1 µM of TTX (Alomone labs, Belgium) for the bath 
perfusion. Charge transfer (Q) was calculated by integrating the area under the PSC 
waveform. The mean PSC synaptic current was calculated as the charge transfer of either the 
averaged sEPSC or sIPSCs multiplied by mean PSC frequency (current × frequency, in femto-
Coulomb/sec. (fCxs-1).  
Electrophysiological properties were evaluated and evoked by 10 currents step injection from 
0 pA to 100 pA in 10 pA increments.  
The amplitude of glycine-elicited currents was assessed by brief and focal applications of 100 
µM glycine that lasted for 5 seconds. Distance of 150-200 μm from the surface of the slice 
was used for focal application using a Warner perfusion system that allowed an exchange 
time of less than 20 ms (Fast-Step, Warner Instrument Corp.). Evaluation of presence of 
synaptic GlyRs was assessed using 5 µM CNQX (C239, Sigma, Belgium), 5 µM AP5 
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(A8054, Sigma), 10 µM of bicuculline methiodide (14343, Sigma, Belgium) and 1 µM 
strychnine (S0532 Sigma, Belgium) in a similar approach used for the sPSCs. 
For the ictal discharge induction, action potentials were measured during subsequently 5 
minutes control in ACSF, 5 minutes in 50, 100 or 500 µM bath applied 4-aminopyridine (4-
AP, Abcam, UK) and a 15 minutes recovery in ACSF.  
Data acquisition was performed using Patchmaster (Heka elektronik) and analyzed using 
pClamp (Molecular Devices, USA) and Clampfit (Molecular Devices) software for glycine 
elicited currents and current-clamp experiments. MiniAnalysis (Synaptosoft, Inc., USA) was 
used for synaptic currents. 
Herpes virus mediated gene transfer. The 450-bp DLX I12b enhancer (Potter et al., 2009) 
was inserted into the LT HSV vector (Fenno et al., 2014), replacing the hCMV promoter and 
thereby generating the following transcriptional cassette: Dlx I12b-GFP-WPRE-poly(A) site. 
The Dlx vector was packaged into virus using the amplicon method (Neve and Lim, 2013).  
The titer of the virus preparation was 3.5 x 108 infectious units (i.u.)/ml. Slices from P7 mice 
were removed from recording chamber and infected for 1-3 days. Slices were fixed overnight 
in 4% PFA and then stained with rabbit anti-PSD95 (1:100; ab18258, Abcam, UK). 
Seizure induction. Male Glra2KO mice and their wild-type littermates (+/- 12 weeks) were 
used to determine seizure thresholds, based on the pentylenetetrazol (PTZ)-induced 
stereotyped seizure behavior. The threshold for the different phases of PTZ-induced seizure 
activity was determined by infusing a solution containing 7.5 mg/ml of PTZ (Sigma Chemical 
Company, St. Louis, MO, USA) with 5000 IE/mL heparin dissolved in 0.9% NaCl solution. 
The infusion was injected through a 29G needle, attached to polyethylene tubing (Smiths, 
Keene, USA) and inserted into the tail vein of the animals at a constant rate of 150 μl/min, 
using a Hamilton syringe mounted to an infusion pump (CMA, Microdialysis, Solna, 
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Sweden). The animals were allowed to move freely in a cage made of plexiglas.  The 
following endpoints were used to determine the seizure threshold: (1) ear twitch; (2) 
myoclonic twitch; (3) forelimb clonus, (4) clonus with loss of righting reflexes (falling); (5) 
THE; (6) death. Time was measured from the start of the PTZ infusion until the onset of these 
stages. The seizure thresholds were individually determined for each animal according to the 
following equation: dose (mg/kg) = duration of infusion (s) × rate of infusion (ml/min) × drug 
concentration (mg/ml) × 1000/(60 s × weight of mouse (g)). 
Neuronal reconstruction. PNs and GFP-expressing INs of the layer V were filled with 
biocytin via the patch pipette and the 300 µm slices were fixed in 4% PFA for 1-2 hours. 
Reconstruction and semi-automated analysis of dendrite morphology, spines and bouton 
density were performed in silico. Biocytin-filled PNs and INs were reconstructed using 
Neuromantic (freeware software by Myatt, D.R.) which was used to calculated branching 
points and total dendritic length. Sholl analyses was performed by using Fiji Image J plug-in 
and analyzed using the linear method (Schindelin et al., 2012, Ferreira et al., 2014) 
Cell counting and spine density. All cellular quantifications were performed in the brightest 
single plane along the Z-stack. Analysis of cell counts was carried out using the manual cell 
counter tool included ImageJ. Fiji Image J plugin was used to measure single dendrite length 
and count dendritic spines throughout the Z-stack.  
Statistics. All data are expressed as mean ± standard error of the mean (SEM). Mean and 
error calculations, as well as statistical analyses were computed in GraphPad (GraphPad 
Software, Inc). Paired and unpaired t-test were used after Shapiro-Wilk normality test, while 
two-way Anova with Bonferroni post hoc test was used for Sholl analysis, bin percentages of 
cells and developmental qPCR for GlyRs. 
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Supplemental information: Supplemental Information includes eight figures and 
Supplemental experimental Procedures and can be found with this article online  
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Figure Legends 
 
Figure 1. Genetic disruption of Glra2 results in microcephaly and reduction in cortical thickness. a, 
low magnification Glra2KO images showing reduction of brain size (scale bar 1000 μm) correlated 
with a decrease in brain weight in P7 Glra2KO mouse as compared to WT control. Values are 
expressed as mean ± SEM, n=7 WT and 7 Glra2KO P7 mice; *p<0.05, t-test. b, cortical thickness at 
P7 in Glra2KO mice in dorsal (D), dorsolateral (D-L) and lateral (L) somatosensory cortex (scale bar 
500 μm). Values are expressed as mean ± SEM, n=7 WT and 7 Glra2KO P7 mice; *p<0.05, 
**p<0.01, t-test. c-d, immunolabelings performed on brain section showing cells expressing Cux1 
(green, c) Ctip2 (red, d), Tbr1 (green, d) and the nuclear label Dapi (blue, d) in P7 WT or Glra2KO 
mice (scale bar 100 μm). Layer II/III and V PNs are significantly decreased at P7, while layer VI do 
not show difference between genotypes. Values are expressed as mean ± SEM, n=20 WT and 20 
Glra2KO brain sections taken from 6 brains per genotype; **p<0.01, ***p<0.001, t-test. 
 
Figure 2. Genetic deletion of Glra2 results in reduction of different subtype of INs within the cerebral 
cortex. a, immunolabelings for Dlx 5-6 GFP+ INs at P7 showing overall reduction of INs without 
major differences in redistribution through division of cortex in bins of equal size (scale bar 100 μm). 
Values are expressed as mean ± SEM, n=12 WT and 12 Glra2KO taken from 3 brains per genotype; 
**p<0.01; t-test and two-way Anova with Bonferroni post hoc tests for bins division. b, 
immunolabeling for somatostatin INs (red, SST) and nuclear staining Dapi (blue) in P7 somatosensory 
cortices showing no differences in number and distribution between WT and Glra2KO (scale bar 100 
μm). Values are expressed as mean ± SEM, n=12 WT and 12 Glra2KO taken from 3 brains per 
genotype; t-test and two-way Anova with Bonferroni post hocs for bins division. c, immunolabelings 
performed on brain section showing INs expressing parvalbumin (red, PV) and the nuclear label Dapi 
(blue) in P14 WT or Glra2KO mice (scale bar 100 μm). No major redistribution was observed, but 
overall reduction in Glra2KO mice. Values are expressed as mean ± SEM, n=16 WT and 16 Glra2KO 
brain sections taken from 4 brains per genotype ***p<0.001, t-test and two-way Anova with 
Bonferroni post hoc tests for bins division. d, immunolabeling for calretinin INs (red, CR) in P7 brain 
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showing a reduction in number in the Glra2KO mice (scale bar 100 μm). Values are expressed as 
mean ± SEM, n=12 WT and 12 Glra2KO taken from 3 brains per genotype; **p<0.01, t-test. 
 
Figure 3. Morphological defects of layer V PNs at P7. a, reconstruction of biocytin-filled P7 layer V 
PNs showing increase in total dendritic length and branching points in Glra2KO mice (scale bar 100 
μm). Values are expressed as mean ± SEM, n=11 WT and 8 Glra2KO P7 mice; **p<0.01, t-test. b, 
Sholl analyses of apical dendrites (top) and basal dendrites (bottom) of layer V PNs (scale bars 50 
μm). Values are expressed as mean ± SEM, n=11 WT and 8 Glra2KO P7 mice; *p< 0.05, **p<0.01, 
***p<0.001, two-way Anova with Bonferroni post hocs. c, spine density on basal dendrites of layer V 
PNs at P7 displaying a decrease in spine density in Glra2KO mice at P7 (scale bar 1 μm). Total 
number of spines was calculated as follow: total dendritic length × spine density). Values are 
expressed as mean ± SEM, n=11 WT and 8 Glra2KO P7 mice; *p<0.05, t-test. d, PSD95 (red) bouton 
density at the level of dendrites of biocytin- filled PNs of the layer V (green) at P7 (scale bar 1 μm). 
Values are expressed as mean ± SEM, n=10 WT and 10 Glra2KO neurons from 3 animals per 
genotype; *p< 0.05; t-test.  
 
Figure 4. Morphological defects of layer V GFP+ INs at P7. a, reconstruction of biocytin-filled P7 
GFP+ INs of the layer V showing increase of total dendritic length and branching points in Glra2KO 
mice (scale bar 100 μm). Values are expressed as mean ± SEM, n=12 WT and 15 Glra2KO P7 mice; 
*p<0.05, t-test. b, Sholl analyses of GFP+ INs. Dendrites show increased branching complexity at the 
dendrites of Glra2KO mice (scale bar 50 μm). Values are expressed as mean ± SEM, n=12 WT and 15 
Glra2KO P7 mice; *p< 0.05, **p<0.01, ***p<0.001, two-way Anova with Bonferroni post hoc test. c, 
spine density on dendrites of GFP+ INs of the layer V at P7 displaying a decrease of spine density in 
Glra2KO mice (scale bar 1 μm). Total number of spines was calculated as follow: total dendritic 
length × spine density. Values are expressed as mean ± SEM, n=12 WT and 15 Glra2KO P7 mice; 
*p<0.05, t-test. d, PSD95 (red) bouton density representing shafts at the level of dendrites of Dlx1 
GFP+ INs (green) at P7 (scale bar 1 μm). Values are expressed as mean ± SEM, n=15 WT and 15 
Glra2KO neurons from 3 animals per genotype; ***p<0.001; t-test.  
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Figure 5. Spontaneous post-synaptic currents and electrophysiological parameters of layer V PNs and 
GFP+INs in acute P7 brain slices. a, representative traces and action potential firing of neurons 
projecting to subcortical area of the brain in the layer V at P7 in WT and Glra2KO mice (scale bar 10 
mV,100 ms). Electrophysiological properties were evaluated and evoked by 10 currents step injection 
from 0 pA to 100 pA in 10 pA increments. No difference was observed in firing rate as showed with 
50 pA injection. b, table representing electrophysiological parameters of layer V PNs. Capacitance is 
significantly increased in Glra2KO PNs (**p<0.01), while rheobase is reduced in the Glra2KO PNs (* 
p<0.05). Values are expressed as mean ± SEM, n=56 for WT and n=38 for Glra2KO neurons used for 
several electrophysiological approaches. c, representative traces of spontaneous post-synaptic currents 
obtained in layer V PNs in ACSF showing increase in frequency in Glra2KO neurons (scale bar 32 
pA, 10 s). Close up picture shows representative traces of single event displaying defect in rise time 
10-90% and amplitude but not decay time (scale bar is 20 pA, 50 ms). Values are expressed as mean ± 
SEM, n=56 for WT and n=38 for Glra2KO neurons used for several electrophysiological approaches; 
* p<0.05, ** p<0.01, *** p<0.001; t-test. d, representative traces and action potential firing of 
GFP+ INs with fast-spiking behavior in the layer V at P7 in WT and Glra2KO mice (scale bar 10 mV, 
100 ms). Electrophysiological properties were evaluated and evoked by 10 currents step injection from 
0 pA to 100 pA in 10 pA increments. No difference was observed in firing rate as showed with 30 pA 
injection. e, table representing electrophysiological parameters of layer V GFP+ INs. Capacitance and 
input resistance are significantly increased in Glra2KO INs (respectively *p<0.05 and **p<0.01), 
while rheobase is decreased in Glra2KO INs (***p<0.01); n=25 for WT and n=31 for Glra2KO 
interneurons. Values are expressed as mean ± SEM. f, representative traces of spontaneous post-
synaptic currents obtained in layer V INs obtained in ACSF showing increase in frequency in 
Glra2KO INs (scale bar 32 pA, 10 s). Close up picture showing of single event displaying defect in 
rise time 10-90% but not decay time and amplitude (scale bar is 20 pA, 50 ms). Values are expressed 
as mean ± SEM, n=25 for WT and n=31 for Glra2KO interneurons; *p<0.05; t-test.  
 
Figure 6. Glra2 deletion leads to alteration of synaptic activity of layer V projection neurons. Whole-
cell patch-clamp analyses performed on layer V PNs in acute P7 brain slices. a, representative traces 
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of excitatory post-synaptic currents obtained in layer V PNs after bath application of 10 μM 
bicuculline showing increase in frequency in Glra2KO neurons (scale bar 32 pA, 10 s). 
Magnifications show representative traces of single event displaying defect in charge transfer (fC/s) 
(scale bar 10 pA, 50 ms). Values are expressed as mean ± SEM, n=24 WT and 17 Glra2KO neurons 
taken from at least 10 mice per genotype; *p<0.05, **p<0.01; t-test. b, triple immunolabeling 
performed on P7 brain section showing layer V PNs expressing Ctip2 (bottom panels, violet), NeuN 
(top panel, green) and excitatory postsynaptic marker PSD95 (top panel, red) (scale bar 10 μm). 
Density of PSD95 perisomatic boutons was manually counted showing an increase in Glra2KO mice. 
Values are expressed as mean ± SEM, n=30 WT and 30 Glra2KO neurons from 3 animals per 
genotype; ***p<0.001; t-test. c, representative traces of inhibitory post-synaptic currents obtained in 
layer V PNs after bath application of 5 μM CNQX and 5 μM AP5 showing decrease in frequency in 
Glra2KO neurons (scale bar 32 pA, 10 s). Zoomed pictures show representative traces of single event 
displaying charge transfer defect (fC/s) (scale bar 10 pA, 50 ms). Values are expressed as mean ± 
SEM, n=46 WT and 21 Glra2KO cells from at least 10 animals per genotype; *p<0.05; t-test. d, triple 
immunolabeling performed on P7 brain section showing layer V PNs expressing Ctip2 (bottom panels, 
violet), NeuN (top panel, green) and inhibitory marker GAD65 (top panel, red) (scale bar 10 μm). 
Density of GAD65 perisomatic boutons was manually counted showing a decrease in Glra2KO mice. 
Values are expressed as mean ± SEM, n=30 WT and 30 Glra2KO neurons from 3 animals per 
genotype; ***p<0.001; t-test.  
 
Figure 7. Glra2 disruption leads to alteration of synaptic activity of layer V GFP+ INs. Whole-cell 
patch-clamp analyses performed on layer V GFP+ INs in acute P7 brain slices. a, representative traces 
of excitatory post-synaptic currents obtained in layer V GFP+ INs after bath application of 10 μM 
bicuculline showing increase in frequency in Glra2KO neurons (scale bar 32 pA, 10 s). Magnified 
picture showing a representative traces of single event displaying  charge transfer defect (fC/s) (scale 
bar 10 pA, 50 ms). Values are expressed as mean ± SEM, n=18 WT and 19 Glra2KO INs from at least 
10 mice per genotype; *p<0.05; t-test. b, double immunolabeling performed on P7 brain section 
showing layer V GFP+ INs (green) and excitatory postsynaptic marker PSD95 (red) (scale bar 10 μm). 
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Density of PSD95 perisomatic boutons was manually counted showing an increase in Glra2KO mice. 
Values are expressed as mean ± SEM, n=30 WT and 30 Glra2KO neurons from 3 animals per 
genotype; ***p<0.001; t-test. c, representative traces of inhibitory post-synaptic currents obtained in 
layer V GFP+ INs after bath application of 5 μM CNQX and 5 μM AP5 showing decrease in frequency 
in Glra2KO INs (scale bar 32 pA, 10 s). Magnifications show representative traces of single event 
displaying defect in charge transfer (fC/s) (scale bar is 10 pA, 50 ms). Values are expressed as mean ± 
SEM, n=22 WT and 31 Glra2KO INs from at least 10 mice per genotype; *p<0.05; t-test. d, double 
immunolabeling performed on P7 brain section showing layer V GFP+ INs (green) and inhibitory 
marker GAD65 (red) (scale bar 10 μm). Density of GAD65 perisomatic boutons was manually 
counted showing a decrease in Glra2KO mice. Values are expressed as mean ± SEM, n=30 WT and 
30 Glra2KO neurons from 3 animals per genotype; ***p<0.001; t-test. 
 
Figure 8. Genetic targeting of Glra2 induces increased susceptibility to drug-induced epilepsy. a, 
summary scheme illustrating cortical synaptic defects in the layer V of the cerebral cortex of WT or 
Glra2KO pups. PNs of layer V (green) present more ramification and total number of spines, despite 
the spine density appears to be reduced for each dendrite. Same pattern of morphology appears in layer 
V INs (red). Reduction in number of PNs of upper layers (blue), layer V (green) and overall number of 
INs (grey and red) occurs in the cerebral cortex of Glra2KO mice. These defects leads to less 
inhibitory input to PNs and INs while an increase in excitatory inputs to PNs and INs. b, table 
representing all morphological and functional defects occurring in PNs and INs of the layer V at P7. c, 
representative traces of 100 µM 4-AP bath application in adult WT or Glra2KO showing more 
susceptibility to 4-AP-induced ictal discharges in depletion upon Glra2 (scale 10 mV, 1 min), n=4 per 
group for 50 µM, n=6 per group 100 µM and n=3 per group 500 µM. d, histogram of the typical 
seizure-related behavioral alterations following PTZ in adult WT and Glra2KO showing a higher 
susceptibility to epileptic seizures induced by PTZ in Glra2KO adult mice (THE= tonic hind limb 
extension). Values are expressed as mean ± SEM, n=12 WT and 11 Glra2KO mice, not all mice 
showed forelimb clonus n=7 WT and 8 Glra2KO mice ;*p<0.05, ***p<0.001; t-test  
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Supplemental figure and legends 
Figure S1. Gross morphological and cellular defects of  P14 Glra2KO mice. a, low magnification 
illustration of microcephaly at P14 in Glra2KO mice showing reduction of brain size (scale bar 1000 
μm) correlated with a decrease in brain weight. Values are expressed as mean ± SEM, n=7 for each 
genotype, Glra2KO P14 mice; *p<0.05, t-test. b, representation of reduction of cortical thickness at 
P14 in Glra2KO mice in dorsal (D), dorsolateral (D-L) and lateral (L) somatosensory cortex (scale bar 
500 μm). Values are expressed as mean ± SEM, n=7 for each genotype, Glra2KO P14 mice; *p<0.05, 
t-test. c-d, immunolabelings performed on brain section showing cells expressing Cux1 (green, c) 
Ctip2 (red, d), Tbr1 (green, d) and the nuclear label Dapi (blue, d) in P14 WT or Glra2KO mice (scale 
bar 100 μm). Layer II/III and V PNs are significantly decreased at P14, while layer VI do not show 
difference between genotypes. Values are expressed as mean ± SEM, n=20 WT and 20 Glra2KO brain 
sections taken from 6 brains per genotype; *p<0.05, **p<0.01, t-test. e, immunolabelings for Dlx 5-6 
GFP+ INs at P14 showing overall reduction of INs without major differences in redistribution through 
division of cortex in bins of equal size (scale bar 100 μm). Values are expressed as mean ± SEM, n=12 
WT and 12 Glra2KO taken from 3 brains per genotype; *p<0.05; t-test and two-way Anova with 
Bonferroni post hoc tests for bins division. f, immunolabeling for somatostatin INs (red, SST) and 
nuclear staining Dapi (blue) in P14 somatosensory cortices showing no differences in number and 
distribution between WT and Glra2KO (scale bar 100 μm). Values are expressed as mean ± SEM, 
n=12 WT and 12 Glra2KO taken from 3 brains per genotype; t-test and two-way Anova with 
Bonferroni post hocs for bins division. 
 
Figure S2. Golgi staining for layer V PNs dendritic spine density and distribution at P7 in Glra2KO 
mice. Representative picture of layer V PNs dendritic spines at P7 in Glra2KO mice showing 
decreased spine density and altered percentage of distribution of mushroom and filamentous but not of 
stub spines (scale bar 1 μm). Values are expressed as mean ± SEM, n=5 for each genotype at P7; 
*p<0.05, ***p<0.001, t-test. 
 
Figure S3.  Rise time, decay time and amplitude of layer V PNs and GFP+INs in Glra2KO at P7. a, 
graphs representing the rise time, decay time and amplitude for sEPSCs showing a decrease in rise 
time 10-90% of layer V PNs in Glra2KO. Values are expressed as mean ± SEM, n=24 WT and 17 
Glra2KO neurons; **p<0.01; t-test. b, graphs representing the rise time, decay time and amplitude for 
sIPSCs showing a decrease in rise time 10-90% and amplitude of layer V PNs in Glra2KO. Values are 
expressed as mean ± SEM, n=46 WT and 21 Glra2KO neurons; *p<0.05; t-test. c, graphs representing 
the rise time, decay time and amplitude for sEPSCs showing a decrease in rise time 10-90% and 
increase in decay time of layer V GFP+ INs in Glra2KO. Values are expressed as mean ± SEM, n=18 
WT and 19 Glra2KO neurons; *p<0.05; t-test. d, graphs representing the rise time, decay time and 
amplitude for sIPSCs showing an increase in rise time 10-90% and in decay time of layer V GFP+ INs 
in Glra2KO. Values are expressed as mean ± SEM, n=18 WT and 19 Glra2KO neurons; **p<0.01; t-
test.  
 
Figure S4. Lack of GlyRs mediated synaptic currents in PNs and GFP+INs of layer V from P7 
Glra2KO and WT mice. a, representative traces showing GlyRs expression in PNs of the layer V at P7 
in both WT and Glra2KO (scale bar 200 pA, 1 sec). b, representative traces showing the absence of 
GlyRs mediated currents in layer V PNs after bath application of excitatory and inhibitory blockers 
plus strychnine in WT and Glra2KO littermates at P7 (scale bar 5 pA, 1 s). Values are expressed as 
mean ± SEM, n=12 for WT and n=11 for Glra2KO neurons; t-test. c, representative traces showing 
GlyRs expression in GFP+ INs of the layer V at P7 in both WT and Glra2KO (scale bar 200 pA, 1 
sec). d, representative traces displaying the absence of GlyRs-mediated currents in layer V GFP+  INs 
after bath application of excitatory and inhibitory blockers plus strychnine in WT and Glra2KO 
littermates at P7 (scale bar 5 pA, 1 s). Values are expressed as mean ± SEM, n=11 for WT and n=9 for 
Glra2KO interneurons; t-test.  
 
Figure S5. Developmental expression of GlyR subunits in WT and Glra2KO mice somatosensory 
cortex. Relative expression of GlyR α and β subunits expressed in the somatosensory cortex during 
five distinct stages of cortical development. a, normalized developmental expression of all GlyRs 
subunits in somatosensory cortices of WT mice. Values are normalized for the lowest expression of 
development (for α2 P30 while for the other subunits E16). b, developmental expression of α1 subunit 
in the somatosensory cortex in WT and Glra2KO. c, developmental expression of α2 subunit in the 
somatosensory cortex in WT mice. d, developmental expression of α3 subunit in the somatosensory 
cortex in WT and Glra2KO. e, developmental expression of α4 subunit in the somatosensory cortex in 
WT and Glra2KO. f, developmental expression of β subunit in the somatosensory cortex in WT and 
Glra2KO. Values are expressed as mean ± SEM, n=5 WT and 5 Glra2KO mice for E16, P0, P7, P30 
n=4 WT and 4 Glra2KO mice for P14 using two-way Anova with Bonferroni post hoc test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental experimental procedures 
RNA preparation.  RNA was isolated from mouse somatosensory cortex at different developmental 
stages and tissue was snap frozen. Total RNA extraction was performed by using RNeasy Plus mini 
kit (Qiagen, Germany) following manufacturer’s instructions. Synthesis of cDNA was performed by 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystem, Belgium) according to the 
protocol.  
Quantitative real-time PCR (RT-PCR). cDNA amplification was performed using  SYBR green 
master mix (Applied Biosystems) containing: 10mM forward and reverse primers, RNase free water 
and 12.5 ng cDNA template in a total reaction volume of 10 μl. Universal amplification conditions 
were used: initial denaturation for 20 seconds at 95 °C, followed by 40 cycles of 3 seconds at 95 °C 
and 30 seconds at 60 °C. Normalization of RT-PCR data was performed against the most stable 
reference genes as determined by GeNorm software for each age and developmental stage 
(Vandesompele et al., 2002). Hydroxymethylbilane synthase (HMBS), cyclophilin A (CYCA), 
hypoxanthine phosphoribosyl transferase (HPRT) and phosphoglycerate kinase 1 (PGK1) were used 
as reference genes for normalizing the expression of GlyRs during development. Relative 
quantification of gene expression was calculated using the comparative Ct method (2-ΔΔCt). Specificity 
of PCR products was determined using melting curve analysis following the amplification protocol. 
Oligonucleotides. The oligonucleotide primers used (Idt and Eurogentec, Belgium) were 5’-
GATGGGCAACTGTACCTGACTG-3’ and 5’-CTGGGCTCCTCTTGGAATG-3’ for HMBS, 5’-
GCGTCTCCTTCGAGCTGTT-3’ and 5’-AAGTCACCACCCTGGCA-3’ for CYCA, 5’-
CTCATGGACTGATTATGGACAGGAC-3’ and 5’-GCAGGTCAGCAAAGAACTTATAGCC-3’ 
for HPRT, 5’-GAAGGGAAGGGAAAAGATGC-3’ and 5’-GCTATGGGCTCGGTGTGC-3’ for 
PGK1, 5’-GGAAGAGGCGACATCACAA-3’ and 5’-TGGACATCCTCTCTCCGGAC-3’ for α1 
subunit, 5’-CACTGGCAAGTTTACCTGCAT-3’ and 5’-GGAGACCCAGGACAAAATGA-3’ for α2 
subunit, 5’-GCACTGGAGAAGTTTTACCG-3’ and 5’-AAGCAGGCTCGGGAGATGGTGTC -3’ 
for α3 subunit, 5’-CAGCATCAGATTGACCCTCA-3’ and 5’- GCAGGAGCATCTTCTAGCCA -3’ 
for α4 subunit, 5’-CTGTTCATATCAGCACTTTGC-3’  and 5’- GGGATGACAGGCTTGGCAG -3’ 
for the beta  (Heck et al., 1997). The primers for α1, α2, α3, α4 were designed with Primer 3 software 
based on their annotations in National Center for Biotechnology information 
(http://www.ncbi.nlm.nih.gov/).  
Immunohistochemistry. The number of GFP+ cortical INs was evaluated in WT and Glra2KO P7 and 
P14 littermates born from breeding between Dlx 5-6 males and Glra2+/- females mice. Tbr1/Cux1 and 
Tbr1/Ctip2 labeling were performed as follow. Sections were washed three times for 5 min in PBS for 
rehydration of the samples. DNA denaturation and antigen retrieval was performed by incubation of 
the slides in citrate buffer for 20 min at 100°C. Following denaturation, slides were washed three times 
for 5 min in PBS. Blocking non-specific binding was performed by incubating slides 1 hour in PBS 
containing 10% normal donkey serum (NDS, Tremecula, USA) and 0.2% Triton X-100 (Sigma, 
Belgium). Primary goat anti-Cux1 (1:25; Sc-6327, Santa Cruz Biotechnologies, USA) or rat anti-Ctip2 
(1:200; ab18465, Abcam, UK), and rabbit anti-Tbr1 (1:200; ab31940, Abcam, UK) were diluted in 
PBS and slices were incubated in the solution overnight. Secondary donkey anti-goat Alexa 488-555, 
donkey anti-rabbit Alexa 555-647 and donkey anti-rat Alexa 555-647 (A555, A647 and A488, Life 
Technologies, Belgium) dissolved in blocking solution were used at 1:500 for 1 hour at room 
temperature. Slides were mounted with DAPI-containing mounting medium (Vector Laboratories, 
USA) for counterstaining of nuclei. Similar protocol was applied for parvalbumin immunolabeling at 
P14: primary mouse anti-Parvalbumin (1:500, MAB 1572, Millipore, USA) was dissolved in 50% 
blocking solution and Alexa 555 was used as secondary antibody (A555 Life Technologies, Belgium). 
Calretinin and somatostatin were detected applying a similar (excepted antigen retrieval) protocol as 
well as GAD65 and PSD95  triple staining combined either with NeuN and Ctip2 or GFP using the 
following antibodies: mouse anti-calretinin (1:1000, mab1568, Millipore, USA) rat anti-somatostatin 
(1:50, mab354, Millipore, USA), mouse anti-GAD65 (5:100;Developmental studies hybridoma bank, 
USA) and rabbit anti-PSD95 (1:100; ab18258, Abcam, UK), mouse anti-NeuN clone A60 (1:100, 
Millipore, USA) and rabbit anti-NeuN (1:100, Millipore, USA) rabbit anti-GFP (1:200; ab6556, 
Abcam, UK). Double labeling were performed by one step co-incubation with a mixture of the 
appropriate antibodies. One step co-incubation was used for the secondary antibodies (Alexa, 1:500; 
Life Technologies, Belgium). Triple labeling (NeuN/Ctip2 and either GAD65 or PSD95) were carried 
out with two-step incubation in which antibodies were firstly labelled for Ctip2/NeuN in which the 
antigen retrieval is required and then with the synaptic markers antibodies.  
Herpes virus mediated gene transfer. Slice culture was carried out according previous literature 
adding some modifications (Cao et al., 2010). P7 littermates were sacrificed by decapitation and 300 
µm slices were cut in filtered and oxygenated ACSF.  Slice were then recovered at 34°C for 1 hour 
and placed in 6 well plates containing pre-warmed ACSF (34°C) and cell culture inserts (Millipore, 
Ireland). 0.6 µl of HSV specific for Dlx I expressing interneurons was pipetted twice directly over the 
somatosensory cortex and the slices were incubated for 1-3 days at 37° 5% CO2. Afterwards, slices 
were moved to the recording chamber to test the specific interneuronal expression of the virus by 
patch clamp recordings. Slices were fixed overnight in 4% PFA and then stained with rabbit anti-
PSD95 (1:100; ab18258, Abcam, UK).  
Cortical thickness. P7 and P14 brain slices were used to measure cortical thickness in Glra2KO mice. 
Parallel lines from ventricles to the pial surface were used as reference to delineate a perpendicular 
line consisting in the thickness of dorsal (D), dorso-lateral (D-L) and lateral (L).  
Golgi staining. P7 littermates were sacrificed by decapitation. Brains were dissected and washed 
several times in PBS. Staining was carried out using FD Rapid GolgiStain kit and protocol (FD 
Neurotechnologies Inc., Columbia USA). Images were obtained with a Nikon 80i Eclipse fluorescence 
microscope using oil immersion 100X objective. Fiji Image J was used for analysis. 
Neuronal reconstruction. Biocytin-filled pipettes, during patch clamp experiments, were used to 
label either pyramidal neurons or GFP-expressing interneurons. 300 µm slices were removed from the 
recording chamber and fixed with 4% PFA for 1-2 hours. Afterwards, slices were rinsed 3 times with 
PBS and blocked using normal goat serum (NGS, Temecula, USA) 5% for 1 hour at RT. Streptavidin 
AlexaFluor 488 conjugate (S-11223, Life Technologies, Belgium) was used to label projection 
neurons whilst streptavidin AlexaFluor 555 conjugate (S-21381, Life Technologies, Belgium) for 
GFP-expressing interneurons. Biocytin-filled neurons and interneurons were reconstructed using 
Neuromantic (freeware software by Myatt, D.R.) which was used to calculated branching points and 
total dendritic length. Sholl analysis was performed by using Fiji Image J plug-in and analyzed using 
the linear method (Schindelin et al., 2012, Ferreira et al., 2014). The distance from the soma to 300 μm 
was considered for the basal dendrites of PNs, while the distance from the apical dendrite to the end of 
the dendrites was used to measure the apical tufts of PNs. The distance from the soma to 300 μm was 
considered for GFP_ expressing interneurons. Spine and boutons density were calculated using Fiji 
ImageJ Simple Neurite Tracer and Cell Counter plug-in to measure respectively semi-automatically 
and manually the size and length of soma and dendrites and their number of spines and boutons 
(density= n/µm). 
Confocal imaging. Images of labeled brain sections were acquired with a Carl Zeiss Axiovert 200M 
motorized microscope equipped with a LSM 510 META confocal laser scanner system (Carl Zeiss, 
Germany). For cell counting purposes, images were acquired with a Plan Apochromat Plan-Neofluar 
40×/1.3 Oil DIC objectives. For neuronal reconstruction, Plan Apochromat 20×/0.75 was used to 
obtain z-stacks, while for spine density and PSD95 and GAD65 boutons the alpha plan-apochromat 
100x/1.46. The A488 fluorophore was visualized by excitation with the 488 nm emission line of an 
Ar-Ion laser while the A555 and A647 dyes were visualized using the 543 nm spectral line of the He-
Ne laser and the 633 nm spectral line of a second He-Ne laser, respectively. DAPI excitation was 
achieved by two-photon excitation at 750 nm with the light emitted by a mode locked MaiTai laser 
(Spectra Physics, USA). Z stacks were acquired every 1-1.5 μm. More than one Z-stack was acquire to 
capture the whole thickness of the cortex covering the same distance in the VZ. For neuronal 
reconstruction, Z-stacks were used to follow in depth and length the shape of the biocytin filled cells. 
Cell counting and spine density. All cellular quantifications were performed in the brightest single 
plane along the Z-stack acquired with a 40× objective as described above. Analysis of cell counts in 
the developing somatosensory cortex at different ages was carried out using the manual cell counter 
tool included ImageJ. The dimension of analyzed field was either 450 × X μm or 225 × X μm 
according to the Y dimension changes between Glra2KO and WT and differences in age in order to 
cover the entire cortex from the ventricle to the pial surface. Fiji Image J plugin was used for Sholl 
analysis and to count dendritic spines throughout the z-stack.  
Statistics. All data are expressed as mean ± standard error of the mean (SEM). Mean and error 
calculations, as well as statistical analyses were computed in GraphPad (GraphPad Software, Inc). 
Unpaired t-test was used for most of the quantifications, while two-way Anova with Bonferroni post 
hocs was used for Sholl analysis, bin percentages of immunolabelings and developmental qPCR for 
GlyRs. 
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